Target 44-198

Target 44-198

Drug Labeling and Warnings

Drug Details

k">

MOTION SICKNESS- dimenhydrinate tablet 
Target Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Target 44-198

Active ingredient (in each tablet)

Dimenhydrinate 50 mg

Purpose

Antiemetic

Uses

for prevention and treatment of these symptoms associated with motion sickness:

  • nausea
  • vomiting
  • dizziness 

Warnings

Do not use

for children under 2 years of age unless directed by a doctor.

Ask a doctor before use if you have


  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland 

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • marked drowsiness may occur
  • use caution when driving a motor vehicle or operating machinery
  • avoid alcoholic beverages

If pregnant or breast-feeding,

ask a health professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

Directions

  • to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
adults and children
12 years and over

 1 to 2 tablets every 4-6 hours; do not exceed
 8 tablets in 24 hours, or as directed by a doctor

children 6 to
under 12 years
 1/2 to 1 tablet every 6-8 hours; do not exceed 3 tablets
 in 24 hours, or as directed by a doctor
children 2 to
under 6 years
 1/2 tablet every 6-8 hours; do not exceed 1 1/2
 tablets in 24 hours, or as directed by a doctor

Other information

  • each tablet contains: calcium 35 mg
  • TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
  • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • protect from moisture
  • see end flap for expiration date and lot number

Inactive ingredients

croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silica gel, stearic acid 

Questions or comments?

Call 1-800-910-6874

Principal Display Panel

NDC: 11673-198-08

Compare to active ingredient in
Dramamine® Original Formula*

motion sickness relief
dimenhydrinate 50 mg/antiemetic

up & up

helps prevent nausea, dizziness and vomiting
from motion sickness

for adults and children

24 TABLETS

ACTUAL SIZE

094 01 0726  RO4 ID225401
Distributed by Target Corporation
Minneapolis, MN 55403
©2018 Target Brands, Inc.
Shop Target.com

*This product is not manufactured or distributed by Medtech Products Inc., owner of the registered trademark Dramamine® Original Formula.
50844    REV0518D19808

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Target 44-198

Target 44-198

MOTION SICKNESS 
dimenhydrinate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 11673-198
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, CHLORTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
Product Characteristics
ColorWHITEScore2 pieces
ShapeROUNDSize9mm
FlavorImprint Code 44;198
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 11673-198-084 in 1 CARTON12/01/1992
16 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC: 11673-198-022 in 1 CARTON12/01/1992
26 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33612/01/1992
Labeler - Target Corporation (006961700)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464PACK(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867894MANUFACTURE(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.967626305PACK(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867837PACK(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.868734088PACK(11673-198)

Revised: 1/2019
 
Target Corporation


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.